(NASDAQ: ICUI) Icu Medical's forecast annual revenue growth rate of 3.87% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.72%.
Icu Medical's revenue in 2026 is $2,156,785,000.On average, 10 Wall Street analysts forecast ICUI's revenue for 2026 to be $55,360,790,775, with the lowest ICUI revenue forecast at $52,936,413,030, and the highest ICUI revenue forecast at $57,385,271,160. On average, 10 Wall Street analysts forecast ICUI's revenue for 2027 to be $57,810,162,105, with the lowest ICUI revenue forecast at $54,960,893,415, and the highest ICUI revenue forecast at $60,084,578,340.
In 2028, ICUI is forecast to generate $60,459,482,115 in revenue, with the lowest revenue forecast at $57,210,316,065 and the highest revenue forecast at $63,283,757,220.